Mobile App for Pancreatic Cancer
(PROCLAIM Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Promoting CT Engagement for Pancreatic Cancer With App?
How does the mobile app treatment for pancreatic cancer differ from other treatments?
The mobile app for pancreatic cancer is unique because it likely involves a digital approach to managing the condition, which is different from traditional treatments like surgery, chemotherapy, or radiation. This app might offer innovative ways to monitor symptoms, provide patient education, or support treatment adherence, which are not typically features of standard medical treatments.46789
What is the purpose of this trial?
To develop a culturally tailored informational mobile application and test whether it will increase participation among Black pancreatic cancer subjects in clinical trial discussions with their care team.This project aims to identify and address barriers to enrollment of Black subjects in pancreatic cancer clinical trials using a culturally informed mobile health application to promote participation.The clinical trial education and communication needs of Black people with pancreatic cancer will be determined. A new mHealth application for clinical trial education and communication tailored to subject needs will be developed. It was hypothesized that a culturally tailored informational mobile application will increase the participation of Black subjects in clinical trial discussions with their care team among the target population.This study focuses on Black pancreatic cancer subjects, who experience higher mortality rates and lower clinical trial participation than White subjects. Research shows that the disparity between clinical trial participation is in part due to inequitable recruitment practices. This study will use mobile application technology (mHealth app) as an educational, communication, audit, and feedback tool to promote patient-initiated clinical trial discussions among Black people with pancreatic cancer and their cancer care team.
Research Team
Jen J. Yeh
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria
This clinical trial is specifically for Black individuals who have been diagnosed with pancreatic cancer. It aims to address the low participation of this group in clinical trials by using a mobile health application designed to encourage discussions about trials with their healthcare team.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Interview and User Testing
Subjects with pancreatic carcinoma participate in interviews and user testing to determine clinical trial education and communication needs
Follow-up
Participants are monitored for feedback and effectiveness of the mHealth application
Treatment Details
Interventions
- Promoting CT Engagement for Pancreatic Cancer With App
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
Lustgarten Foundation
Collaborator